阿尔茨海默病和血管生物学 - - 专注于促凝状态
Marta Casquero-Veiga1, Carlos Ceron2, Marta Cortes-Canteli3
1Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Current opinion in cell biology
|May 10, 2025
概括
阿尔茨海默病涉及血管问题,特别是血液凝结因子,如纤维素和血小板. 这些成分有助于AD患者的脑病理,神经炎症和血管封闭.
科学领域:
- 神经科学是一个神经科学.
- 血管生物学 血管生物学
- 病理生理学 病理生理学
背景情况:
- 阿尔茨海默病 (AD) 呈现出复杂的,多因素的病理生理学.
- 新出现的证据表明,在AD中,血管功能障碍,包括静血失调和前血栓状态,在AD.
- 阿尔茨海默病的古典标志越来越多地与血管贡献一起被理解.
研究的目的:
- 审查最近关于纤维素和血小板在阿尔茨海默病病理学中的作用的发现.
- 更新对血管功能障碍和AD之间的相互作用的理解.
- 倡导对AD进行综合性研究和个性化方法.
主要方法:
- 文献综述侧重于阿尔茨海默病研究中的最新发现.
- 分析纤维素和血小板在阿尔茨海默病发病过程中的作用.
- 检查血管因素和AD特征之间的相互作用.
主要成果:
- 在AD大脑中的异常纤维素素积累及其与粉样蛋白-β的相互作用.
- 纤维素素对凝块稳定性,血管封闭和神经炎症的影响.
- 有证据表明,血小板在AD连续性中从保护性转变为有害性.
结论:
- 血管因素,特别是纤维素和血小板,是阿尔茨海默病病理学的组成部分.
- 了解血管功能障碍和AD之间的复杂相互作用至关重要.
- 需要全面,整合和个性化的研究策略来解决AD的多面性质.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
546
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
546
Alzheimer's Disease: Overview
323
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
323
Disorders of Hemostasis
647
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
647
Clot Retraction and Fibrinolysis
2.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.8K
Extrinsic and Intrinsic Pathways of Hemostasis
4.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.0K
Coagulation
3.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
3.5K


